- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE and Agfa call off Wanchoo dispute
GE Medical Systems of Milwaukee and Agfa of Ridgefield Park, NJ, have reconciled their dispute over former Agfa PACS executive Vishal Wanchoo, who was hired by GE in November. GE and Agfa parent Bayer announced Dec. 17 that they have resolved the civil
GE Medical Systems of Milwaukee and Agfa of Ridgefield Park, NJ, have reconciled their dispute over former Agfa PACS executive Vishal Wanchoo, who was hired by GE in November. GE and Agfa parent Bayer announced Dec. 17 that they have resolved the civil lawsuit that Bayer filed seeking to prevent Wanchoo from disclosing Agfa trade secrets.
GE brought Wanchoo in to lead its Integrated Imaging Solutions PACS unit, replacing Anthony Lombardo, who has been named general manager of IIS Americas sales. Wanchoo previously had been vice president of marketing at Agfa and was attributed with being one of the players who helped build Agfa into a PACS powerhouse.
GE may have received more than it bargained for in hiring Wanchoo, however. Bayer's lawsuit sought a temporary restraining order to prevent Wanchoo from using Agfa trade secrets and confidential customer information. The legal imbroglio was the talk of the exhibit floor at this month's Radiological Society of North America meeting.
Both companies apparently decided it was better to settle than fight. The terms of the agreement were not disclosed, but Agfa executive vice president Erhard Rittinghaus said the company was satisfied that the deal would protect its business interests.
GE and Agfa will continue to cooperate in ensuring product compatibility in medical imaging archiving systems. The settlement did not include a monetary payment.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
